Social Research ¦ Market Research ¦ Behavioural Insight ¦ Evaluation ¦ SROI
M·E·L Research was commissioned by the Wales Cancer Network to help assess the outcomes and impact of the all-Wales Rapid Diagnosis Clinics (RDC) programme.
The RDC programme was a national initiative supporting Health Boards in Wales to provide General Practitioners (GPs) with a referral pathway and RDC to investigate vague symptoms that may be caused by cancer. RDCs aimed to:
• Support earlier diagnosis for patients with vague, non-specific symptoms that could be cancer
• Reduce cancer diagnoses via emergency presentations
• Improve overall patient health outcomes by detecting cancer earlier
• Improve patient and GP experience
• Identify and manage other serious non-malignant disease or those at risk of developing serious illness
• Provide reassurance and early discharge for those patients with no, or non-serious disease, thus increasing capacity through appropriate and efficient use of finite services
We carried out a summative evaluation, using primary and secondary research evidence, to assess the impact of the programme and whether the above aims were achieved. Although the RDC programme in Wales was a national programme, the approach had been adopted by taking into account the local context within all Health Boards operating an RDC. It was therefore crucial for us to capture the unique learning from each locality to support new developments and future rollout.
The evaluation highlighted several significant achievements of the RDC programme:
Despite these successes, the evaluation also identified several challenges:
To ensure the sustainability and further development of the RDC programme, the evaluation provided several recommendations:
The evaluation by M·E·L Research underscores the critical role of RDCs in the Welsh healthcare system. The forward planning workshop based on the key findings facilitated discussions on service improvement, future direction and sustainability to continue to enhance RDC services, ensuring timely and accurate diagnoses for patients across Wales, and ultimately to improve cancer care pathways and outcomes for patients with vague symptoms.